8BK3
Crystal structure of the transpeptidase LdtMt2 from Mycobacterium tuberculosis in complex with diepoxide ketone 1
Summary for 8BK3
Entry DOI | 10.2210/pdb8bk3/pdb |
Descriptor | L,D-transpeptidase 2, 1-[(2~{S},3~{R})-3-phenyloxiran-2-yl]ethanone, NITRATE ION, ... (7 entities in total) |
Functional Keywords | l, d-transpeptidase, ldtmt2, inhibitor, covalent, antimicrobial protein |
Biological source | Mycobacterium tuberculosis |
Total number of polymer chains | 2 |
Total formula weight | 76738.92 |
Authors | de Munnik, M.,Schofield, C.J. (deposition date: 2022-11-08, release date: 2023-11-22, Last modification date: 2024-10-16) |
Primary citation | de Munnik, M.,Lithgow, J.,Brewitz, L.,Christensen, K.E.,Bates, R.H.,Rodriguez-Miquel, B.,Schofield, C.J. alpha beta , alpha ' beta '-Diepoxyketones are mechanism-based inhibitors of nucleophilic cysteine enzymes. Chem.Commun.(Camb.), 59:12859-12862, 2023 Cited by PubMed Abstract: Epoxides are an established class of electrophilic alkylating agents that react with nucleophilic protein residues. We report αβ,α'β'-diepoxyketones (DEKs) as a new type of mechanism-based inhibitors of nucleophilic cysteine enzymes. Studies with the L,D-transpeptidase Ldt from and the main protease from SARS-CoV-2 (M) reveal that following epoxide ring opening by a nucleophilic cysteine, further reactions can occur, leading to irreversible alkylation. PubMed: 37815791DOI: 10.1039/d3cc02932h PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.15 Å) |
Structure validation
Download full validation report
